Eli Lilly Q2 adjusted EPS $8.38 on $22.97B revenue beat views, company guides full-year EPS $35.50–$36.50, revenue $85–$87B

• Adjusted EPS of $8.38 topped consensus $6.01, while revenue of $22.97B beat $20.26B estimate.
• Q2 revenue increased 48% year over year to approximately $23.0B.
• Company raised 2026 revenue guidance to $85–$87B and issued full-year EPS guidance of $35.50–$36.50.

https://finviz.com/stock?t=LLY&p=d